Advertisement第120回日本精神神経学会学術総会

Abstract

第119巻第3号

※会員以外の方で全文の閲覧をご希望される場合は、「電子書籍」にてご購入いただけます。
Minds Guide for Developing Clinical Practice Guidelines Ver. 2.0 by Japan Council for Quality Health Care―Practice of EBM―
Ryota HASHIMOTO1,2
1 Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University
2 Department of Psychiatry, Osaka University Graduate School of Medicine
Psychiatria et Neurologia Japonica 119: 158-165, 2017

 Minds (Medical Information Network Distribution Service) is an information service provided by the Japan Council for Quality Health Care (JCQHC), a public interest incorporated foundation. The Minds guide for developing clinical practice guidelines was published in 2014.
 The aim of the Minds project is to help medical practitioners fully utilize information related to evidence-based medicine (EBM) in their practice. Minds also provides patients and the public with information to help understand the basics of diseases and share up-to-date evidence with doctors, on which modern medical practices are based. Overall, clinical practice guidelines are made up as follows: 1) a three-layered structure of guideline committees consisting of a managing committee, guideline creation team, and a systematic review team, 2) a clear description of the basis for an individual's judgment and COI, 3) evaluation of the body of evidence summarized for every outcome and study design in all selected research reports for each Clinical Question (CQ), and 4) not only the "benefit" but also the "harm" in the patient outcome caused by intervention are to be included in the evaluation.
 According to the Minds method, the Japanese Society of Neuropsychopharmacology has created a "Guidelines for Pharmacological Therapy of Schizophrenia." These guidelines were introduced to explain the characteristics of the Minds method in this paper. The Effectiveness of GUIdelines for Dissemination and Education in psychiatric treatment project (EGUIDE project) was also introduced to disseminate and evaluate these guidelines.
 <Author's abstract>

Keywords:guidelines, minds, EBM (evidence-based medicine), guidelines for pharmacological therapy of schizophrenia, EGUIDE project>
Advertisement

ページの先頭へ

Copyright © The Japanese Society of Psychiatry and Neurology